Stanford Cancer Institute posted on LinkedIn:
“With a new cancer case diagnosed every 15 seconds in the United States and the global burden of the disease rising, Stanford Medicine has begun charting a bold course to better understand, prevent, and treat the disease.
“At the heart of our vision is a deep integration of research and clinical practice – seeing them not as isolated functions but as essential parts of a virtuous cycle,” said Lloyd Minor, MD, the Carl and Elizabeth Naumann Professor for the Dean of the School of Medicine and vice president for medical affairs at Stanford University. “We want to develop an engine of cancer innovation where lab-based discoveries rapidly reach patients and clinical experiences immediately inform research.”
This transformative undertaking will integrate expertise from across the university to advance cancer research, technology and patient-centered care. As part of this strategic initiative, Stanford Medicine has begun exploring the development of an integrated cancer research and clinical care center in Redwood City. Co-locating these facilities would accelerate cutting-edge research and care while also supporting and enhancing Stanford Medicine’s entire cancer-focused network, from Palo Alto to the South Bay and East Bay.
Other articles from Stanford Cancer Institute on OncoDaily.